Clinical Trials in Arizona

Showing 14621-14640 of 16,770 trials

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

NCT01306630

This is an open-label, multi-center, dose-finding study of tivozanib administered in combination with capecitabine. During the dose-escalation portion, sequential cohorts of subjects with advanced solid tumors will be enrolled in order to establish the maximum tolerated dose (MTD). If the MTD is not reached, the recommended Phase 2 dose (RP2D) will be determined. In the expansion cohort, subjects with locally advanced or metastatic breast or colon cancer will be enrolled at MTD (or RP2D) to further evaluate safety and activity of this combination in these tumor types.

Advanced Solid TumorsLocally Advanced or Metastatic Breast or Colorectal Cancer

AVEO Pharmaceuticals, Inc.24 participantsStarted Nov 2010

Scottsdale, Arizona, United States • Fort Myers, Florida, United States • Nashville, Tennessee, United States

COMPLETEDPhase 2108 miles

Phase 2 Chronic Low Back Pain Study

NCT01364922

The primary purpose of this study was to evaluate the analgesic effect and safety of hydrocodone/acetaminophen extended release compared to placebo.

Chronic Low Back Pain

AbbVie (prior sponsor, Abbott)168 participantsStarted Jun 2011

Tucson, Arizona, United States • Anaheim, California, United States • Burbank, California, United States +14 more locations

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

Phase 2 Chronic Low Back Pain Study

Find Trials by Condition in Arizona

Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension

Study to Evaluate the Prospective Payment System

Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Clinical Evaluation of the Crosstrees Pod™ in the Treatment of Pathologic Fracture of the Vertebral Body (Levels T4 - L5) in Adult Patients

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

Kidney and Liver Transplantation in People With HIV

A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in CRC Screening

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes